Cited by — Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.
No admitted local citation edges point to this work yet.
